ArticleAntimicrobial agents and chemotherapy2012

Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitor.

Meiqing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.